The VI Young Researchers Awards 2022 organised by the AstraZeneca Foundation in collaboration with the Carlos III Health Institute took place yesterday. Juan Manuel Corchado, Director of the BISITE Research Group and President of the AIR Institute, along with other members of the Board of Trustees of the AstraZeneca Foundation, the Minister of Science and Innovation, Diana Morant, and other figures from the health and pharmaceutical sectors, attended the ceremony to recognise the work of the award-winning researchers.
Minister Morante highlighted the commitment to standardising advanced therapies; one of the objectives of the Strategic Project for Economic Recovery and Transformation (PERTE). “Spain is already a world leader in the clinical trials of these cutting-edge therapies and, in a few years’ time, we will make these new personalised precision medications available in the public health system,” she said.
This year’ s edition was held under the slogan “Connections that change lives”, in which one million euros were awarded to the five winners. The selected projects were related to Oncology, Precision Medicine and Immuno-Oncology, Respiratory Medicine and Immunology, Cardiovascular, Renal and Metabolism Medicine, and Vaccines and Immunotherapies. During the gala, the career of biochemist Mariano Barbacid was also recognised.
Our joy was even greater as we had the opportunity to accompany the team from the Institute of Biomedical Research of Salamanca (IBSAL) and, in particular, Mónica del Rey, who was awarded in the category of Oncology, Precision Medicine and Immuno-oncology, with the project “Germinal predisposition to myelodysplastic syndromes in adults: expanding diagnostic accuracy and evidence of pathogenicity”, coordinated by Andrés Jerez, from the Morales Meseguer University Hospital in Murcia. Also, the Murcia Institute of Biosanitary Research-Pascual Parrilla, the Cancer Research Centre of the University of Salamanca (IBSAL), the University Clinical Hospital of Santiago de Compostela in Galicia, the University Clinic of Navarra and the Vall d’Hebron Institute of Oncology in Catalonia are collaborating in this project.
Initiatives of this kind are a great way of promoting research in Spain. We have much talent and this is reflected in our position in the scientific field, not only in Europe, but also worldwide.